home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

ISO 14971-Risk Management Standards Revisions

 
  June 06, 2016  
     
 
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
July 12, 2016 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend?
This online training is intended for professionals in the Medical Device/Diagnostics Industry. It will be especially valuable to the following:

  • Regulatory
  • Quality
  • Clinical personnel

Those involved with interpreting EU requirements and interpretation of the risk management file to ISO 14971:2012 (the most recent revision) will benefit greatly from this training. 

Course Description
This 90-minute accredited training will offer attendees new insight into the recent changes made regarding the ISO 14971-Risk Management Standards. It will help professionals focus on the significant revisions that need close attention and will give a good explanation as to how the older risk management standards can be made current with the newest interpretation in the most efficient and effective manner. What the medical device industry struggles with however is how to handle extensive documentation to older versions of ISO 14971:2012; this course can provide you some tools (with use of disclaimer statements, etc.) how to revise older versions of your risk management files. Finally, this course takes a peek at some of the “position papers” of some Notified Bodies interpretations on the newly revised standard and will assist you in understanding these changes.
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Jack Slovick, Founder, Methodize Incorporated

Mr. Jack Slovic has worked in the medical device and diagnostics industry since 1981. Throughout his career, he has gained a variety of experiences in regulatory, quality, and clinical services.

In 2004, Mr. Slovick founded the consulting business, Methodize Incorporated. He wanted to offer results-oriented, strategic skills to a broader range of companies in need of approval for their medical devices and in-vitro diagnostics products. Mr. Slovick has worked in the medical device industry for over 35+ years operating in various Regulatory, Quality and Clinical leadership positions. His experience covers all kinds of modalities including Catheter Stroke therapy, Catheter thrombosis, Orthopedics, wound care management, etc. He is presently a qualified auditor (on a contract basis) performing ISO 13485/MDD audits as well as technical file reviews for a Notified Body (Intertek). Mr. Slovick has consulted and/ or audited over 100 companies in the modalities mentioned and has had to put together risk management files for or audited these various RMF files for technical file/ design dossier approvals. He also has submitted (e.g., through 510k, IDE or PMA) files through FDA as well as set up systems and escort FDA inspection personnel who may have inspected RMF information.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: jmorbit@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.